About 30-40% of patients dont see meaningful additional loss when phentermine is added after a GLP-1 plateau
[9] [10] The American Society of Anesthesiologists (ASA) and other medical societies have issued guidance on this topic, with updated recommendations in 2024 that move away from blanket cessation toward a more individualized, risk-stratified approach
To maintain transparency and uphold our quality standards, we provide Certificates of Analysis (COAs) issued by an independent, accredited laboratory
These investigations should include evaluation of both acute and chronic effects of peptide administration
Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell
For a regular patient with vitamin B12 deficiency, the doctors usually start with a high dosage